Michael E. Ballard, PhD - Publications

Affiliations: 
Neurology University of California, San Francisco, San Francisco, CA 
Area:
behavior, psychopharmacology, human neuroimaging, PET, fMRI, stimulants, cannabinoids, cognition, delay discounting, executive function, memory, emotional processing, working memory
Website:
http://profiles.ucsf.edu/michael.ballard

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Moeller SJ, Okita K, Robertson CL, Ballard ME, Konova AB, Goldstein RZ, Mandelkern MA, London ED. Low Striatal Dopamine D2-Type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28664927 DOI: 10.1038/npp.2017.138  0.68
2015 Ballard ME, Dean AC, Mandelkern MA, London ED. Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users. Plos One. 10: e0143510. PMID 26657223 DOI: 10.1371/journal.pone.0143510  1
2015 Ballard ME, Weafer J, Gallo DA, de Wit H. Effects of acute methamphetamine on emotional memory formation in humans: encoding vs consolidation. Plos One. 10: e0117062. PMID 25679982 DOI: 10.1371/journal.pone.0117062  1
2015 Ballard ME, Mandelkern MA, Monterosso JR, Hsu E, Robertson CL, Ishibashi K, Dean AC, London ED. Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18: pyu119. PMID 25603861 DOI: 10.1093/ijnp/pyu119  1
2014 London ED, Kohno M, Morales AM, Ballard ME. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Research. PMID 25451127 DOI: 10.1016/j.brainres.2014.10.044  1
2014 Ballard ME, Gallo DA, de Wit H. Amphetamine increases errors during episodic memory retrieval. Journal of Clinical Psychopharmacology. 34: 85-92. PMID 24135845 DOI: 10.1097/JCP.0000000000000039  1
2013 Ballard ME, Gallo DA, de Wit H. Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans. Psychopharmacology. 226: 515-29. PMID 23224510 DOI: 10.1007/s00213-012-2924-5  1
2012 Ballard ME, Bedi G, de Wit H. Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. Journal of Psychopharmacology (Oxford, England). 26: 1289-98. PMID 22585232 DOI: 10.1177/0269881112446530  1
2012 Ballard ME, Gallo DA, de Wit H. Psychoactive drugs and false memory: comparison of dextroamphetamine and δ-9-tetrahydrocannabinol on false recognition. Psychopharmacology. 219: 15-24. PMID 21647577 DOI: 10.1007/s00213-011-2374-5  1
2011 Ballard ME, de Wit H. Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers. Pharmacology, Biochemistry, and Behavior. 97: 627-31. PMID 21110996 DOI: 10.1016/j.pbb.2010.11.013  1
2011 Zhang M, Ballard ME, Basso AM, Bratcher N, Browman KE, Curzon P, Konno R, Meyer AH, Rueter LE. Behavioral characterization of a mutant mouse strain lacking D-amino acid oxidase activity. Behavioural Brain Research. 217: 81-7. PMID 20933022 DOI: 10.1016/j.bbr.2010.09.030  1
2008 White DA, Ballard ME, Harmon AC, Holtzman SG. Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption. Brain Research Bulletin. 76: 597-604. PMID 18598850 DOI: 10.1016/j.brainresbull.2008.04.002  1
2007 Zhang M, Ballard ME, Unger LV, Haupt A, Gross G, Decker MW, Drescher KU, Rueter LE. Effects of antipsychotics and selective D3 antagonists on PPI deficits induced by PD 128907 and apomorphine. Behavioural Brain Research. 182: 1-11. PMID 17570538 DOI: 10.1016/j.bbr.2007.04.021  1
2007 Ballard ME, Basso AM, Gallagher KB, Browman KE, Fox GB, Drescher KU, Gross G, Decker MW, Rueter LE, Zhang M. The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment. Psychopharmacology. 190: 1-11. PMID 17093979 DOI: 10.1007/s00213-006-0577-y  1
2006 Zhang M, Ballard ME, Kohlhaas KL, Browman KE, Jongen-Rêlo AL, Unger LV, Fox GB, Gross G, Decker MW, Drescher KU, Rueter LE. Effect of dopamine D3 antagonists on PPI in DBA/2J mice or PPI deficit induced by neonatal ventral hippocampal lesions in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1382-92. PMID 16395300 DOI: 10.1038/sj.npp.1300985  1
2005 Fox GB, Esbenshade TA, Pan JB, Browman KE, Zhang M, Ballard ME, Radek RJ, Miner H, Bitner RS, Krueger KM, Yao BB, Faghih R, Rueter LE, Komater VA, Drescher KU, et al. Selective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia. Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]. 54: S23-4. PMID 15928819 DOI: 10.1007/s00011-004-0410-1  1
2005 Zhang M, Ballard ME, Pan L, Roberts S, Faghih R, Cowart M, Esbenshade TA, Fox GB, Decker MW, Hancock AA, Rueter LE. Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. Brain Research. 1045: 142-9. PMID 15910772 DOI: 10.1016/j.brainres.2005.03.018  1
2005 Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, et al. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. The Journal of Pharmacology and Experimental Therapeutics. 313: 176-90. PMID 15608077 DOI: 10.1124/jpet.104.078402  1
2004 Rueter LE, Ballard ME, Gallagher KB, Basso AM, Curzon P, Kohlhaas KL. Chronic low dose risperidone and clozapine alleviate positive but not negative symptoms in the rat neonatal ventral hippocampal lesion model of schizophrenia. Psychopharmacology. 176: 312-9. PMID 15179541 DOI: 10.1007/s00213-004-1897-4  1
Show low-probability matches.